Is Chloral Hydrate Reasonable and Necessary?
Reasonable and Necessary determination guidance for Chloral Hydrate (ORION CHLORAL HYDRATE MIXTURE 500mg/10mL bottle) on workers compensation and personal injury claims.
Whether Chloral Hydrate (ORION CHLORAL HYDRATE MIXTURE 500mg/10mL bottle) is reasonable and necessary depends on the compensable injury, prescribing duration, and clinical justification. Chloral Hydrate is classified as Moderate risk by AllMeds. It is S4 under the TGA in Australia. Guidelines recommend a maximum duration of 7 days for acute use. Claims professionals should assess whether the prescribing is directly related to the injury, within clinical guidelines for duration and dose, and not for a pre-existing condition.
Key Takeaways
- Risk level: Moderate (3 points)
- Schedule: S4 in Australia
- Duration guideline: Maximum 7 days. Beyond this requires documented clinical justification.
- Opioid: R&N determination required for prescribing beyond acute phase. Review against CDC/SIRA/NICE guidelines.
- Key question: Is Chloral Hydrate being prescribed for the compensable injury, or for a pre-existing or unrelated condition?
R&N Assessment: When Is Chloral Hydrate Injury-Related?
Possibly Related - Requires Clinical Justification
- Chronic pain from a workplace injury beyond 12 weeks
- Pain management during active rehabilitation
Duration and Dose Guidelines
Recommended maximum duration: 7 days for acute prescribing. Continuation beyond this requires documented clinical justification, evidence of functional improvement, and a documented treatment plan with tapering strategy.
Opioid R&N Thresholds by Jurisdiction
| Jurisdiction | Guideline | R&N Threshold |
|---|---|---|
| AU - NSW (SIRA) | SIRA Best Practice Opioid Management | Review required beyond acute phase. Long-term use requires specialist justification. |
| AU - VIC (WorkSafe) | WorkSafe Drugs of Dependence Guidelines | Monitoring required for all S8 opioids. Duration and dose should be regularly reviewed. |
| US (CDC) | CDC Clinical Practice Guideline 2022 | Non-opioid therapies preferred. If opioids used, lowest effective dose for shortest duration. Reassess at 1-4 weeks. |
| UK (NICE) | NICE NG193 Chronic Pain | Do not initiate opioids for chronic primary pain. Review ongoing opioid therapy regularly. |
How to Make the R&N Determination
- Check injury relatedness: Is Chloral Hydrate being prescribed for the compensable injury, or for a pre-existing or unrelated condition?
- Review clinical justification: Does the treating doctor's documentation explain why Chloral Hydrate is necessary for this specific injury?
- Assess duration: Is the prescribing duration within clinical guidelines? Guideline maximum: 7 days.
- Check for alternatives: Have safer or more appropriate treatments been trialled first?
- Review interactions: Is Chloral Hydrate being combined with other medications that create additional risk?
- Document your determination: Record the R&N decision, rationale, and any actions taken in the claim file.
Need to assess this medication across your caseload?
Run an automated R&N determination for Chloral Hydrate against the compensable injury. AllMeds scores every medication as directly related, possibly related, or unrelated.
AllMeds gives you instant risk assessments, compliance checks, and automated letters for every medication on a claim.
No credit card required. No signup for your first 2 questions.
Related Resources
Medical Disclaimer: This content is for informational purposes for claims professionals and care workers. It is not medical advice. Always consult a qualified healthcare professional for clinical decisions. Drug information is sourced from TGA, FDA, MHRA, PBS, NICE, and CDC databases and may not reflect the latest updates. AllMeds does not replace clinical judgement.